Qsemble Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Buy
+2,635
New +$324K 0.05% 318
2026
Q1
Sell
-3,728
Closed -$611K 592
2025
Q4
$611K Buy
3,728
+291
+8% +$45.6K 0.05% 350
2025
Q3
$459K Sell
3,437
-434
-11% -$52.7K 0.05% 340
2025
Q2
$481K Buy
+3,871
New +$493K 0.05% 326
2024
Q3
Sell
-1,853
Closed -$234K 528
2024
Q2
$234K Buy
+1,853
New +$290K 0.04% 381
2024
Q1
Sell
-2,275
Closed -$409K 512
2023
Q4
$409K Buy
+2,275
New +$354K 0.1% 263
2023
Q3
Sell
-2,800
Closed -$396K 396
2023
Q2
$396K Buy
+2,800
New +$449K 0.28% 129

Other funds holding RGEN

Qsemble Capital Management's RGEN Position: Q2 2026 in Review

Qsemble Capital Management opened a new position in Repligen (RGEN) in Q2 2026: 2,635 shares worth $360K. The stake represents 0.05% of the portfolio and ranks #318 among its holdings. This is a return to the name: Qsemble Capital Management previously reported a position in RGEN as recently as Q4 2025.

Qsemble Capital Management first reported a position in RGEN in Q2 2023 and has held it in 7 quarters since. The position peaked at $611K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Qsemble Capital Management held 2,635 shares of Repligen worth $360K as of Q2 2026.
  • Repligen was a new Qsemble Capital Management position in Q2 2026.
  • Repligen made up 0.05% of Qsemble Capital Management's portfolio in Q2 2026, its #318 holding.
  • Qsemble Capital Management first reported a position in Repligen in Q2 2023 and has held it in 7 quarters since.
  • Qsemble Capital Management's Repligen position peaked at $611K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.